National and Kapodistrian University of Athens
Επίδραση της νεφρικής συμπαθητικής απονεύρωσης στο μεταβολισμό της γλυκόζης σε υπερτασικούς ασθενείς με μεταβολικό σύνδρομο
Abstract
dc:descriptionObjective: This study investigated the role of renal denervation(RDN) in glucose metabolism in hypertensive patients with metabolic syndrome.Methods:40 patients underwent RDN (and 30 were the control group).Mean age was 56.87±7.12 years and 6.7% were women. Mean value of BMI was 31.23±4.37 kg/height2,waist circumference 108.62±10.82cm,hip 110.47±8.45cm and weight 94.50±14.97kg.Mean systolic blood pressure (SBP)was 165±17.33mmHg,diastolic blood pressure(DBP) 96.47±9.91mmHg and heart rate(HR) 75.22±10.86 beats/min. Ambulatory Blood Pressure Measurements(ABPM) for 24h SBP, DBP and HR were 144.67±12.25mmHg, 96.47±9.91mmHg, 75.22±10.86 beats/min respectively.47.5% were on 2 antihypertensives,40% on 3 and 12.5% on 4.All were receiving ACE/AA II 100%, β blocker 30%, AA 6.7% and 60% diuretics. Mean fasting glucose was 122.35±21.79mg/dl, HbA1c 6.17 ±0.84%, insulin 11.83±4.98μ IU/ml, HOMA-IR index 3.66±2.19 and ISQuicki 0.31±0.01.Μean value for GFR 93.79±21.33 ml/min.1.73m2,ΑC 32.84±78.18mg/g,CHOL, HDL, LDL, TG and VLDL were 196.87±40.53mg/dl, 45.32±10.04mg/dl, 121.37±35.55mg/dl, 168.30±120.46mg/dl and 32.85±23.75mg/dl respectively. Results: RDN contributed to the reduction of office SBP (-11.13±16.30mmHg, p=0.001), DBP (-7.66±8.44, p=0.004) at 3 months and at one year (-19.23/-10.53 ± 14.31 /8.08, p=0.003/0.004 respectively).In the 24-hour recording we had a decrease in 24-hour SBP and DBP at 3 months (-7.40±14.20mmHg,p=0.008 and -3.06±3.71mmHg,p=0.029 respectively) and 12 months (-11.66 ±11.88,p=0.003 and -7.70±6.56,p=0.004 respectively).At 3 and 12 months after RDN the mean fasting glucose value compared to the initial visit was -7.20±12.13mg/dl (p=0.003) and at one year -13.60±20.38mg/dl (p=0.001). Insulin increased at 3 months by 0.87±4.57IU/μL(p=0.302) while at 12 months we had a decrease by -0.70±3.98(p=0.344). The RDN group had an increase in the HOMA-IR resistance index at 3 months by 0.04±1.65(p=0.895) while at 12 there was a decrease of -0.62±1.78(p=0.066). The ISQuicki sensitivity index showed a slight increase at 3 and 12 months by 0.0006±0.02(p=0.855) and 0.006±0.02(p= 0.095) respectively. No statistically significant difference was noted in the glucose and insulin values when performing the OGTT at 3 and 12 months. In control group we had no significant difference in 3 and 12 months. Patients had in all measurements reduction in blood pressure but without statistical significance. Conclusion: RDN did not lead to an improvement in the glycemic profile of the patients. It contributed, as other studies have shown, to the reduction of BP values
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koutra, Evangelia
- Κούτρα, Ευαγγελία
Subjects
dc:subject × 16- Συμπαθητική απονεύρωση
- Απονεύρωση
- Μεταβολισμός
- Γλυκόζη
- Μεταβολικό σύνδρομο
- Renal denervation
- Denervation
- Glucose
- Metabolism
- Metabolic syndrome
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Καρδιολογία και Καρδιοαγγειακά νοσήματα
- Clinical Medicine
- Medical and Health Sciences
- Cardiology and Cardiovascular Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56200